If you liked this article you might like

'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts
Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business
Trifecta Stocks Portfolio: Fattening Up on the Trump Trade Before the Holiday